Inhibition of PTTG1 expression or activity can suppress the metastasis of pancreatic cancer cells, suggesting that PTTG1 may be a potential target for the development of novel anticancer therapies. This evidence concerns the gene PTTG1 and familial pancreatic carcinoma.